- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05008497
Cancer and Literacy in Health (CaLiS)
June 28, 2024 updated by: GCS Ramsay Santé pour l'Enseignement et la Recherche
Validation in French of a Psychometric Tool for Measuring Health Literacy in the Field of Cancer
Validation in French of a psychometric tool for measuring health literacy in the field of cancer
Study Overview
Detailed Description
Single-centre, non-interventional questionnaire study
Study Type
Observational
Enrollment (Estimated)
1300
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Charlotte NGO, MD
- Phone Number: 33 06 64 12 31 05
- Email: Charlotte.ngo@senogyneco.com
Study Locations
-
-
-
Paris, France, 75013
- Recruiting
- Hôpital Privé des Peupliers, Ramsay Santé
-
Contact:
- Charlotte Ngo, MD
- Phone Number: 33 0664123105
- Email: charlotte.ngo@senogyneco.com
-
Contact:
- Charlotte Ngo, MD
- Email: charlotte.ngo@senogyneco.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
all patients followed or having been followed for cancer at the Hôpital privé des Peupliers between May 2014 and December 2020
Description
Inclusion Criteria:
- Patient aged 18 years or older, having been informed of the research
- Followed or having been followed at the Hôpital privé des Peupliers for a cancer
Exclusion Criteria:
- Patient who has indicated his/her opposition to the use of his/her medical data
- Patient under legal protection, guardianship or curatorship
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Validation of a questionnaire
Time Frame: 6 months
|
Development of the questionnaire: translation of the English version, testing of the French version in group work and then back-translation.
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Charlotte NGO, MD PD, Hôpital Privé des Peupliers, Ramsay Santé
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 18, 2021
Primary Completion (Estimated)
March 31, 2025
Study Completion (Estimated)
March 31, 2025
Study Registration Dates
First Submitted
August 16, 2021
First Submitted That Met QC Criteria
August 16, 2021
First Posted (Actual)
August 17, 2021
Study Record Updates
Last Update Posted (Actual)
July 1, 2024
Last Update Submitted That Met QC Criteria
June 28, 2024
Last Verified
June 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- 2021-A00421-40
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.